Abstract

Investigations of human autoimmune diseases have largely involved study of circulating T cells. The development of T-cell cloning technology has made possible the study of the small numbers of T cells found at sites of pathological involvement in autoimmune diseases. In this initial communication, the feasibility of in vitro propagation of synovial fluid T cells from patients with arthritis is demonstrated. The generation of long-term, phenotypic helper/inducer, as well as phenotypic suppressor/cytotoxic, interleukin 2-dependent synovial fluid T-cell lines from patients with arthritis is reported. The ability to generate such synovial fluid T-cell lines should now allow for new investigative approaches to human autoimmune arthritic diseases.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.